ACC 2018 Conference
ACC 2018 Conference
Advertisement
DocWire News EditorsACC 2018 Conference | April 11, 2023
A “triple pill” combination therapy consisting of three different blood pressure medications reduced blood pressure ...
Read More
DocWire News EditorsACC 2018 Conference | April 6, 2023
An analysis of a subset of patients from the CANTOS trial suggested that canakinumab does not prevent prediabetes from ...
DocWire News EditorsACC 2018 Conference | April 10, 2023
A month-long treatment regimen with a novel inhaled inorganic nitrate yielded no significant improvement in exercise ...
DocWire News EditorsACC 2018 Conference | April 3, 2023
The beta-blocker carvedilol showed some benefit for protecting against heart injury resulting from chemotherapy-induced ...
DocWire News EditorsACC 2018 Conference | September 6, 2023
Results from the MOMENTUM- 3 trial, presented at the 2018 American College of Cardiology Scientific Sessions (ACC.18) ...
DocWire News EditorsACC 2018 Conference | September 11, 2023
Patients younger than 75 years of age who suffered an MI and were given ticagrelor did not see an increased risk for ...
DocWire News EditorsACC 2018 Conference | January 17, 2019
Patients who suffered MI and who were given payment vouchers to reduce their co-payments were more likely to adhere to ...
DocWire News EditorsACC 2018 Conference | April 11, 2023
In patients who recently suffered an acute coronary syndrome (ACS), the PCSK9 inhibitor alirocumab was associated with a ...
Advertisement
Advertisement
Advertisement
Latest News

January 2, 2025